ArticleMolecular therapy. Nucleic acids2022

Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers.

Si-Ping Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.